These results, along with a earlier report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the notion of targeting ACKR3 as a novel approach to modulate the opioid system, which could open new therapeutic avenues for opioid-connected disorders. At that point, Microsoft Advertising and https://klause380gyz5.blogunok.com/profile